Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.

Changchien CH, Chen SW, Chen YY, Chu C.

BMC Infect Dis. 2016 Jun 10;16(1):276. doi: 10.1186/s12879-016-1630-z.

2.

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies.

Dunne MW, Talbot GH, Boucher HW, Wilcox M, Puttagunta S.

Drug Saf. 2016 Feb;39(2):147-57. doi: 10.1007/s40264-015-0374-9.

3.

Biomedical applications of nisin.

Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL.

J Appl Microbiol. 2016 Jun;120(6):1449-65. doi: 10.1111/jam.13033. Epub 2016 Feb 12. Review.

PMID:
26678028
4.

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection.

Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J.

Clin Infect Dis. 2016 Mar 1;62(5):545-51. doi: 10.1093/cid/civ982. Epub 2015 Nov 26.

5.

Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance.

Quave CL, Lyles JT, Kavanaugh JS, Nelson K, Parlet CP, Crosby HA, Heilmann KP, Horswill AR.

PLoS One. 2015 Aug 21;10(8):e0136486. doi: 10.1371/journal.pone.0136486. eCollection 2015.

6.

Variable performance of models for predicting methicillin-resistant Staphylococcus aureus carriage in European surgical wards.

Lee AS, Pan A, Harbarth S, Patroni A, Chalfine A, Daikos GL, Garilli S, Martínez JA, Cooper BS; MOSAR-04 Study Team.

BMC Infect Dis. 2015 Feb 27;15:105. doi: 10.1186/s12879-015-0834-y.

7.

Is Community-Acquired Methicillin-Resistant Staphylococcus aureus Coverage Needed for Cellulitis?

Horseman M, Bowman JD.

Infect Dis Ther. 2013 Dec;2(2):175-85. doi: 10.1007/s40121-013-0019-1. Epub 2013 Nov 12.

8.

The evolving role of chemical synthesis in antibacterial drug discovery.

Wright PM, Seiple IB, Myers AG.

Angew Chem Int Ed Engl. 2014 Aug 18;53(34):8840-69. doi: 10.1002/anie.201310843. Epub 2014 Jul 2. Review.

9.

Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides.

Ryu S, Song PI, Seo CH, Cheong H, Park Y.

Int J Mol Sci. 2014 May 16;15(5):8753-72. doi: 10.3390/ijms15058753. Review.

10.

Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.

Rajamuthiah R, Fuchs BB, Jayamani E, Kim Y, Larkins-Ford J, Conery A, Ausubel FM, Mylonakis E.

PLoS One. 2014 Feb 19;9(2):e89189. doi: 10.1371/journal.pone.0089189. eCollection 2014.

11.

All purulence is local - epidemiology and management of skin and soft tissue infections in three urban emergency departments.

Merritt C, Haran JP, Mintzer J, Stricker J, Merchant RC.

BMC Emerg Med. 2013 Dec 20;13:26. doi: 10.1186/1471-227X-13-26.

12.

Does the nose know? An update on MRSA decolonization strategies.

Abad CL, Pulia MS, Safdar N.

Curr Infect Dis Rep. 2013 Dec;15(6):455-64. doi: 10.1007/s11908-013-0364-y.

13.

Molecular epidemiology of Staphylococcus aureus in households of children with community-associated S aureus skin and soft tissue infections.

Rodriguez M, Hogan PG, Burnham CA, Fritz SA.

J Pediatr. 2014 Jan;164(1):105-11. doi: 10.1016/j.jpeds.2013.08.072. Epub 2013 Oct 13.

14.

Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.

Santos PD, Davis A, Jandourek A, Smith A, David Friedland H.

J Chemother. 2013 Dec;25(6):341-6. doi: 10.1179/1973947813Y.0000000144. Epub 2013 Dec 6.

15.

Emergency ultrasound-assisted examination of skin and soft tissue infections in the pediatric emergency department.

Marin JR, Dean AJ, Bilker WB, Panebianco NL, Brown NJ, Alpern ER.

Acad Emerg Med. 2013 Jun;20(6):545-53. doi: 10.1111/acem.12148.

16.

Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice.

Heunis TD, Smith C, Dicks LM.

Antimicrob Agents Chemother. 2013 Aug;57(8):3928-35. doi: 10.1128/AAC.00622-13. Epub 2013 Jun 3.

17.

A peptide-morpholino oligomer conjugate targeting Staphylococcus aureus gyrA mRNA improves healing in an infected mouse cutaneous wound model.

Sawyer AJ, Wesolowski D, Gandotra N, Stojadinovic A, Izadjoo M, Altman S, Kyriakides TR.

Int J Pharm. 2013 Sep 10;453(2):651-5. doi: 10.1016/j.ijpharm.2013.05.041. Epub 2013 May 29.

18.

Measurement and Impact of Staphylococcus aureus Colonization Pressure in Households.

Rodriguez M, Hogan PG, Krauss M, Warren DK, Fritz SA.

J Pediatric Infect Dis Soc. 2013 Jun;2(2):147-54. doi: 10.1093/jpids/pit002. Epub 2013 Feb 11.

19.

Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone.

Williamson DA, Roberts SA, Ritchie SR, Coombs GW, Fraser JD, Heffernan H.

PLoS One. 2013 Apr 25;8(4):e62020. doi: 10.1371/journal.pone.0062020. Print 2013.

20.

Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice.

Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS.

PLoS Pathog. 2012;8(11):e1003047. doi: 10.1371/journal.ppat.1003047. Epub 2012 Nov 29.

Items per page

Supplemental Content

Write to the Help Desk